1522 / 1544
Rousseau
Cancer
Radioth
2012
10 pts
PTV 723
(392-885
cc)
V5: 13% higher VMAT
V20: 24 vs 20 (p<0.01)
V30: 20 vs 14 (p<0.01)
MLD 14 vs 12.2 Gy
Cattaneo
Radiot
Oncol 2008
13 pts
PTV: 215-
745
Dmean: 20.4 vs 16.8 Gy p=0.001
V5: 67.4 vs 70.4% p= 0.61
V10: 56.4 vs 54.2% p=0.694
V15: 43.1 vs 37.4% p=0.013
V20: 33.5 vs 25.8% p= 0.002
V30: 27 vs 17.5% p=0.001
Scrimger
AMJCO
2003
5 pts
PTV 169cc
(132-280)
TOMO:
Mean lung dose reduction
of 31% (10-53%)
Mean V20 reduction
of 22% (17-37%)
3D vs VMAT-TOMO: LUNG